|Articles|June 1, 2018
- Pharmaceutical Executive-06-01-2018
- Volume 38
- Issue 6
Pharmaceutical Executive, June 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 8 years ago
US Maps Strategy to Reform Drug Pricingabout 8 years ago
C-Suite Personality: Fit for Future?about 8 years ago
Insights for the Winabout 8 years ago
Leveraging Lab Data in Advent of Personalized Marketingabout 8 years ago
Asembia 2018: User-Friendly Urgencyabout 8 years ago
Piecing Together the Pricing Puzzle: The Midterm Electionsabout 8 years ago
Pharm Exec's Top 50 Companies 2018Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond the Megamerger: How Rumored AstraZeneca–BMS Discussions Signal a New Era of Pharmaceutical Competition
2
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
3
FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma
4
Amazon Pharmacy Launches GLP-1 Delivery Service
5